615 related articles for article (PubMed ID: 10473105)
1. Metabolic activation of dacarbazine by human cytochromes P450: the role of CYP1A1, CYP1A2, and CYP2E1.
Reid JM; Kuffel MJ; Miller JK; Rios R; Ames MM
Clin Cancer Res; 1999 Aug; 5(8):2192-7. PubMed ID: 10473105
[TBL] [Abstract][Full Text] [Related]
2. Role of cytochrome P450 isoenzymes in metabolism of O(6)-benzylguanine: implications for dacarbazine activation.
Long L; Dolan ME
Clin Cancer Res; 2001 Dec; 7(12):4239-44. PubMed ID: 11751525
[TBL] [Abstract][Full Text] [Related]
3. Metabolic oxidation and toxification of N-methylformamide catalyzed by the cytochrome P450 isoenzyme CYP2E1.
Hyland R; Gescher A; Thummel K; Schiller C; Jheeta P; Mynett K; Smith AW; Mráz J
Mol Pharmacol; 1992 Feb; 41(2):259-66. PubMed ID: 1538706
[TBL] [Abstract][Full Text] [Related]
4. Impaired dacarbazine activation and 7-ethoxyresorufin deethylation in vitro by polymorphic variants of CYP1A1 and CYP1A2: implications for cancer therapy.
Lewis BC; Korprasertthaworn P; Miners JO
Pharmacogenet Genomics; 2016 Oct; 26(10):453-61. PubMed ID: 27428168
[TBL] [Abstract][Full Text] [Related]
5. Formation of guanoxabenz from guanabenz in human liver. A new metabolic marker for CYP1A2.
Clement B; Demesmaeker M
Drug Metab Dispos; 1997 Nov; 25(11):1266-71. PubMed ID: 9351903
[TBL] [Abstract][Full Text] [Related]
6. [O-methyl 14C]naproxen O-demethylase activity in human liver microsomes: evidence for the involvement of cytochrome P4501A2 and P4502C9/10.
Rodrigues AD; Kukulka MJ; Roberts EM; Ouellet D; Rodgers TR
Drug Metab Dispos; 1996 Jan; 24(1):126-36. PubMed ID: 8825200
[TBL] [Abstract][Full Text] [Related]
7. Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2.
Tassaneeyakul W; Birkett DJ; Veronese ME; McManus ME; Tukey RH; Quattrochi LC; Gelboin HV; Miners JO
J Pharmacol Exp Ther; 1993 Apr; 265(1):401-7. PubMed ID: 8474022
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of dacarbazine by rat liver microsomes contribution of CYP1A enzymes to dacarbazine N-demethylation.
Yamagata S; Ohmori S; Suzuki N; Yoshino M; Hino M; Ishii I; Kitada M
Drug Metab Dispos; 1998 Apr; 26(4):379-82. PubMed ID: 9531528
[TBL] [Abstract][Full Text] [Related]
9. Oxidative metabolism of the alkaloid rutaecarpine by human cytochrome P450.
Ueng YF; Don MJ; Jan WC; Wang SY; Ho LK; Chen CF
Drug Metab Dispos; 2006 May; 34(5):821-7. PubMed ID: 16501007
[TBL] [Abstract][Full Text] [Related]
10. Application of homology modeling to generate CYP1A1 mutants with enhanced activation of the cancer chemotherapeutic prodrug dacarbazine.
Lewis BC; Mackenzie PI; Miners JO
Mol Pharmacol; 2011 Nov; 80(5):879-88. PubMed ID: 21816953
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of 2-amino-alpha-carboline. A food-borne heterocyclic amine mutagen and carcinogen by human and rodent liver microsomes and by human cytochrome P4501A2.
Raza H; King RS; Squires RB; Guengerich FP; Miller DW; Freeman JP; Lang NP; Kadlubar FF
Drug Metab Dispos; 1996 Apr; 24(4):395-400. PubMed ID: 8801053
[TBL] [Abstract][Full Text] [Related]
12. Development of a non-high pressure liquid chromatography assay to determine [14C]chlorzoxazone 6-hydroxylase (CYP2E1) activity in human liver microsomes.
Draper AJ; Madan A; Latham J; Parkinson A
Drug Metab Dispos; 1998 Apr; 26(4):305-12. PubMed ID: 9531516
[TBL] [Abstract][Full Text] [Related]
13. Tobacco smoke-dependent changes in cytochrome P450 1A1, 1A2, and 2E1 protein expressions in fetuses, newborns, pregnant rats, and human placenta.
Czekaj P; Wiaderkiewicz A; Florek E; Wiaderkiewicz R
Arch Toxicol; 2005 Jan; 79(1):13-24. PubMed ID: 15448981
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human cytochrome P450-catalyzed oxidations of xenobiotics and procarcinogens by synthetic organoselenium compounds.
Shimada T; El-Bayoumy K; Upadhyaya P; Sutter TR; Guengerich FP; Yamazaki H
Cancer Res; 1997 Nov; 57(21):4757-64. PubMed ID: 9354437
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of vanoxerine, 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine, by human cytochrome P450 enzymes.
Cherstniakova SA; Bi D; Fuller DR; Mojsiak JZ; Collins JM; Cantilena LR
Drug Metab Dispos; 2001 Sep; 29(9):1216-20. PubMed ID: 11502731
[TBL] [Abstract][Full Text] [Related]
16. Identification of the human liver cytochrome P450 isoenzyme responsible for the 6-methylhydroxylation of the novel anticancer drug 5,6-dimethylxanthenone-4-acetic acid.
Zhou S; Paxton JW; Tingle MD; Kestell P
Drug Metab Dispos; 2000 Dec; 28(12):1449-56. PubMed ID: 11095582
[TBL] [Abstract][Full Text] [Related]
17. Cyp1a2 protects against reactive oxygen production in mouse liver microsomes.
Shertzer HG; Clay CD; Genter MB; Schneider SN; Nebert DW; Dalton TP
Free Radic Biol Med; 2004 Mar; 36(5):605-17. PubMed ID: 14980704
[TBL] [Abstract][Full Text] [Related]
18. Caffeine, estradiol, and progesterone interact with human CYP1A1 and CYP1A2. Evidence from cDNA-directed expression in Saccharomyces cerevisiae.
Eugster HP; Probst M; Würgler FE; Sengstag C
Drug Metab Dispos; 1993; 21(1):43-9. PubMed ID: 8095225
[TBL] [Abstract][Full Text] [Related]
19. Molecular cloning and functional analysis of cytochrome P450 1A2 from Japanese monkey liver: comparison with marmoset cytochrome P450 1A2.
Narimatsu S; Oda M; Hichiya H; Isobe T; Asaoka K; Hanioka N; Yamano S; Shinoda S; Yamamoto S
Chem Biol Interact; 2005 Feb; 152(1):1-12. PubMed ID: 15766918
[TBL] [Abstract][Full Text] [Related]
20. Identification of cytochrome P-450 isoform(s) responsible for the metabolism of pimobendan in human liver microsomes.
Kuriya Si; Ohmori S; Hino M; Ishii I; Nakamura H; Senda C; Igarashi T; Kiuchi M; Kitada M
Drug Metab Dispos; 2000 Jan; 28(1):73-8. PubMed ID: 10611143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
